Related Experiment Video

Updated: Aug 19, 2026

A Macrophage-Tumor Spheroid Co-Invasion Assay
09:01

A Macrophage-Tumor Spheroid Co-Invasion Assay

Published on: January 24, 2025

Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway

Bailong Sun1, Jun Nishihira, Takashi Yoshiki

  • 1Department of Surgery, Hokkaido University Graduate School of Medicine, N15 W7, Sapporo 060-8638, Japan.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|February 15, 2005
PubMed
Abstract

Insights

Macrophage migration inhibitory factor (MIF) promotes tumor invasion and metastasis. Inhibiting MIF with siRNA reduced cancer cell invasion and liver metastasis by affecting the Rho-dependent pathway.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Macrophage migration inhibitory factor (MIF) is implicated in immune responses and tumorigenesis.
  • The specific role of MIF in tumor invasion and metastasis requires further investigation.

Purpose of the Study:

  • To investigate the role of MIF in tumor invasion and metastasis.
  • To elucidate the signaling pathways involved in MIF-mediated tumor progression.

Main Methods:

  • Macrophage migration inhibitory factor (MIF) mRNA was knocked down using small interfering RNA (siRNA) in colon 26 cancer cells.
  • In vitro invasion assays and in vivo metastasis models were employed.
  • Signal transduction pathways, including lysophosphatidic acid (LPA)-induced Rho-dependent signaling, were analyzed.

Main Results:

  • MIF siRNA significantly reduced cancer cell invasion in vitro.
  • MIF knockdown suppressed LPA-induced Rho-dependent signaling, including focal adhesion kinase (FAK) phosphorylation and integrin beta1 expression.
  • In vivo, MIF siRNA pretreatment inhibited liver metastasis.

Conclusions:

  • MIF promotes tumor invasion and metastasis.
  • The Rho-dependent pathway is a key mechanism through which MIF exerts its pro-metastatic effects.
  • Targeting MIF may represent a therapeutic strategy for preventing cancer metastasis.

More Related Videos

In Vitro Assay to Study Tumor-macrophage Interaction08:36

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...